サンプル依頼リスト カート
  • English
  • Korean
表紙：機器免疫組織化学市場：動向、機会、競合分析【2023-2028年】
市場調査レポート
商品コード
1342061

機器免疫組織化学市場：動向、機会、競合分析【2023-2028年】

Equipment Immunohistochemistry Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

機器免疫組織化学市場：動向、機会、競合分析【2023-2028年】
出版日: 2023年08月10日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

機器免疫組織化学市場の動向と予測

世界の装置免疫組織化学市場は、2023年から2028年までのCAGRが5.1%で、2028年までに推定6億2,000万米ドルに達すると予測されます。この市場の主な促進要因は、慢性疾患や感染症の増加、組織サンプル中のタンパク質や高分子のような成分を検査する顕微鏡ベースの技術に対する需要の増加です。免疫組織化学装置市場の将来は、病院、診断研究所、学術機関における機会により有望と思われます。

免疫組織化学装置市場の洞察

  • Lucintelの予測では、固形腫瘍や細胞学的標本の診断に免疫組織化学が大きく利用されているため、診断分野が予測期間中に最も高い成長を遂げる見込みです。
  • 診断検査室は、細胞内の特定の生物学的成分の位置と分布を決定するために免疫組織化学が大きく使用されるため、最大のセグメントであり続けると予想されます。
  • 北米は、診断施設や検査室における免疫組織化学装置への需要の高まり、支援的な償還政策の存在、同地域における老人人口の増加により、最大の地域であり続けると予想されます。

本レポートは以下の11の主要な質問に答えている：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？また、主要企業はどのような戦略的取り組みを進めているのか？
  • Q10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるのか？
  • Q11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の機器免疫組織化学市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

  • マクロ経済動向（2017～2022年）と予測（2023～2028年）
  • 世界の機器免疫組織化学市場動向（2017-2022）と予測（2023-2028）
  • アプリケーション別の世界の機器免疫組織化学市場
    • 診断
    • がん
    • 感染性
    • 腎臓疾患
    • 自己免疫疾患
    • 神経疾患
    • 調査
    • 法医学
    • その他
  • 最終用途別の世界の機器免疫組織化学市場
    • 病院
    • 診断研究所
    • 学術機関
    • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

  • 地域別の世界の機器免疫組織化学市場
  • 北米の機器免疫組織化学市場
  • 欧州の機器免疫組織化学市場
  • アジア太平洋機器免疫組織化学市場
  • その他地域装置免疫組織化学市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • アプリケーション別の世界の機器免疫組織化学市場の成長機会
    • 最終用途別の世界の機器免疫組織化学市場の成長機会
    • 地域別の世界の機器免疫組織化学市場の成長機会
  • 世界の機器免疫組織化学市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の機器免疫組織化学市場の能力拡大
    • 世界の機器免疫組織化学市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories
目次

Equipment Immunohistochemistry Market Trends and Forecast

The future of the equipment immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes. The global equipment immunohistochemistry market is expected to reach an estimated $0.62 billion by 2028 with a CAGR of 5.1% from 2023 to 2028. The major drivers for this market are rising number chronic and infectious diseases and increasing demand for microscopy-based techniques to examine components, like protein and macromolecules, in a tissue sample.

A more than 150-page report is developed to help in your business decisions.

Equipment Immunohistochemistry Market by Segment

The study includes trends and forecast for the global equipment immunohistochemistry market by application, end use, and region, as follows:

Equipment Immunohistochemistry Market by Application [Shipment Analysis by Value from 2017 to 2028]:

  • Diagnostics
  • Cancer
  • Infectious
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Research
  • Forensic
  • Others

Equipment Immunohistochemistry Market by End Use [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals
  • Diagnostic Laboratories
  • Academic Institutes
  • Others

Equipment Immunohistochemistry Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Equipment Immunohistochemistry Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies equipment immunohistochemistry companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the equipment immunohistochemistry companies profiled in this report include.

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories

Equipment Immunohistochemistry Market Insights

  • Lucintel forecasts that diagnostic segment is expected to witness the highest growth over the forecast period due to the significant usage of immunohistochemistry for diagnosis of solid tumors and cytological specimens.
  • Diagnostic laboratory is expected to remain the largest segment due to the significant use of immunohistochemistry for determining the location and distribution of particular biological components within cells.
  • North America will remain the largest region due to the growing demand for immunohistochemistry equipment in diagnostic facilities and laboratories, presence of supportive reimbursement policies, and rising number of geriatric population in the region.

Features of the Equipment Immunohistochemistry Market

  • Market Size Estimates: Equipment immunohistochemistry market size estimation in terms of value ($B)
  • Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Equipment immunohistochemistry market size by various segments, such as by application, end use, and region
  • Regional Analysis: Equipment immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different applications, end uses, and regions for the equipment immunohistochemistry market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the equipment immunohistochemistry market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the equipment immunohistochemistry market size?

Answer: The global equipment immunohistochemistry market is expected to reach an estimated $0.62 billion by 2028.

Q2. What is the growth forecast for equipment immunohistochemistry market?

Answer: The global equipment immunohistochemistry market is expected to grow with a CAGR of 5.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the equipment immunohistochemistry market?

Answer: The major drivers for this market are rising number chronic and infectious diseases and increasing demand for microscopy-based techniques to examine components, like protein and macromolecules, in a tissue sample.

Q4. What are the major segments for equipment immunohistochemistry market?

Answer: The future of the equipment immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes.

Q5. Who are the key equipment immunohistochemistry companies?

Answer: Some of the key equipment immunohistochemistry companies are as follows:

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories

Q6. Which equipment immunohistochemistry segment will be the largest in future?

Answer: Lucintel forecasts that diagnostic segment is expected to witness the highest growth over the forecast period due to the significant usage of immunohistochemistry for diagnosis of solid tumors and cytological specimens.

Q7. In equipment immunohistochemistry market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to the growing demand for immunohistochemistry equipment in diagnostic facilities and laboratories, presence of supportive reimbursement policies, and rising number of geriatric population in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global equipment immunohistochemistry market by application (diagnostics, cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, research, forensic, and others), end use (hospitals, diagnostic laboratories, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Equipment Immunohistochemistry Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Equipment Immunohistochemistry Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Equipment Immunohistochemistry Market by Application
    • 3.3.1: Diagnostics
    • 3.3.2: Cancer
    • 3.3.3: Infectious
    • 3.3.4: Nephrological Diseases
    • 3.3.5: Autoimmune Diseases
    • 3.3.6: Neurological Diseases
    • 3.3.7: Research
    • 3.3.8: Forensic
    • 3.3.9: Others
  • 3.4: Global Equipment Immunohistochemistry Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostic Laboratories
    • 3.4.3: Academic Institutes
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Equipment Immunohistochemistry Market by Region
  • 4.2: North American Equipment Immunohistochemistry Market
    • 4.2.1: North American Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.2.2: North American Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.3: European Equipment Immunohistochemistry Market
    • 4.3.1: European Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.3.2: European Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.4: APAC Equipment Immunohistochemistry Market
    • 4.4.1: APAC Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.4.2: APAC Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.5: ROW Equipment Immunohistochemistry Market
    • 4.5.1: ROW Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.5.2: ROW Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Equipment Immunohistochemistry Market by Application
    • 6.1.2: Growth Opportunities for the Global Equipment Immunohistochemistry Market by End Use
    • 6.1.3: Growth Opportunities for the Global Equipment Immunohistochemistry Market by Region
  • 6.2: Emerging Trends in the Global Equipment Immunohistochemistry Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Equipment Immunohistochemistry Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Equipment Immunohistochemistry Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Roche
  • 7.2: Agilent Technologies
  • 7.3: Danaher
  • 7.4: PHC Holding
  • 7.5: Biocare Medical
  • 7.6: Merck
  • 7.7: Bio-Rad Laboratories